All comparisons

Educational Wellness Information Only

This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.

Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.

Clinical comparison

Carbetocin (Duratocin) vs Plecanatide (Trulance)

An educational, source-based comparison of Carbetocin (Duratocin) and Plecanatide (Trulance) — how each peptide works, what it's researched for, and what to know before going deeper.

Oxytocin Analog · Obstetrics
Carbetocin (Duratocin)

Long-acting oxytocin analog for postpartum hemorrhage prevention.

Mechanism

Synthetic, heat-stable oxytocin analog with longer half-life. Stimulates uterine contraction following delivery to prevent postpartum hemorrhage.

Research areas
  • Postpartum hemorrhage prevention (C-section, vaginal delivery)
Considerations
  • FDA-approved (also widely used internationally).
  • Single-dose use only.
Full Carbetocin (Duratocin) profile →
GC-C Agonist · Gastrointestinal
Plecanatide (Trulance)

Uroguanylin analog for chronic constipation.

Mechanism

Synthetic analog of human uroguanylin that activates guanylate cyclase-C in a pH-dependent manner, increasing intestinal fluid secretion and transit.

Research areas
  • Chronic idiopathic constipation
  • IBS-C
Considerations
  • FDA-approved.
  • Diarrhea most common adverse event.
Full Plecanatide (Trulance) profile →

Trial-evidence rating

Educational grade reflecting how many peer-reviewed studies and FDA actions we cite for each peptide. Not a clinical recommendation.

Carbetocin (Duratocin)
Strong

FDA-approved with published clinical trial data.

1 cited study
Plecanatide (Trulance)
Strong

FDA-approved with published clinical trial data.

1 cited study

Study-by-study comparison

PeptideStudySourceYearSummary
Carbetocin (Duratocin)WHO CHAMPION trialNEJM2018Heat-stable carbetocin non-inferior to oxytocin for PPH prevention.
Plecanatide (Trulance)Plecanatide phase 3American Journal of Gastroenterology2017Significantly improved complete spontaneous bowel movements vs placebo.

Side-effect & safety grid

Carbetocin (Duratocin)
  • FDA-approved (also widely used internationally).
  • Single-dose use only.
Plecanatide (Trulance)
  • FDA-approved.
  • Diarrhea most common adverse event.

Educational summary of considerations reported in research literature — not a complete list of adverse events. Discuss with a licensed clinician before any use.

Carbetocin (Duratocin) vs Plecanatide (Trulance) — Key differences

  • Class: Carbetocin (Duratocin) is classified as Oxytocin Analog · Obstetrics, while Plecanatide (Trulance) is GC-C Agonist · Gastrointestinal.
  • Primary research focus: Carbetocin (Duratocin)postpartum hemorrhage prevention (c-section, vaginal delivery); Plecanatide (Trulance)chronic idiopathic constipation.
  • Tag: FDA-Approved · Obstetrics vs FDA-Approved · GI.

Related comparisons